propofol has been researched along with Cancer of Esophagus in 23 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interruption of sedation due to a poor response to modified neuroleptanalgesia (m-NLA) with midazolam often occurs during endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) because most patients have a history of heavy alcohol intake." | 9.27 | Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial. ( Arakawa, T; Fujiwara, Y; Fukunaga, S; Kamata, N; Kato, K; Machida, H; Maruyama, H; Minamino, H; Nagami, Y; Ominami, M; Sakai, T; Shiba, M; Sugimori, S; Tanaka, F; Tanigawa, T; Tominaga, K; Watanabe, T; Yamagami, H, 2018) |
| "BACKGROUND This study was done to verify whether propofol could inhibit esophageal squamous cell carcinoma (ESCC) cell line EC9706 cell migration and invasion by targeting SOX4." | 7.85 | Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4). ( Ji, P; Li, JJ; Zhou, CL, 2017) |
| "We present a case of severe hyperkalemia in a 48-year-old man after short-term infusion of an average dose of propofol." | 7.75 | Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome? ( Mali, AR; Mistry, RC; Patil, VP; Pramesh, CS, 2009) |
| "Interruption of sedation due to a poor response to modified neuroleptanalgesia (m-NLA) with midazolam often occurs during endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) because most patients have a history of heavy alcohol intake." | 5.27 | Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial. ( Arakawa, T; Fujiwara, Y; Fukunaga, S; Kamata, N; Kato, K; Machida, H; Maruyama, H; Minamino, H; Nagami, Y; Ominami, M; Sakai, T; Shiba, M; Sugimori, S; Tanaka, F; Tanigawa, T; Tominaga, K; Watanabe, T; Yamagami, H, 2018) |
| "BACKGROUND This study was done to verify whether propofol could inhibit esophageal squamous cell carcinoma (ESCC) cell line EC9706 cell migration and invasion by targeting SOX4." | 3.85 | Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4). ( Ji, P; Li, JJ; Zhou, CL, 2017) |
| "We present a case of severe hyperkalemia in a 48-year-old man after short-term infusion of an average dose of propofol." | 3.75 | Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome? ( Mali, AR; Mistry, RC; Patil, VP; Pramesh, CS, 2009) |
| "Patients with superficial esophageal cancers who underwent esophageal endoscopic submucosal dissection at Yokohama City University Hospital were prospectively enrolled and were randomly assigned to the propofol and the propofol plus dexmedetomidine groups." | 3.01 | Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection. ( Arimoto, J; Ashikari, K; Chiba, H; Fuyuki, A; Higurashi, T; Kanoshima, K; Matsuura, T; Misawa, N; Nakajima, A; Nonaka, T; Ohkubo, H; Takatsu, T; Yoshihara, T, 2021) |
| "Propofol is a pharmaceutical agent commonly used as an intravenous anesthetic in surgical treatments and a sedative in intensive care." | 1.91 | Propofol elicits apoptosis and attenuates cell growth in esophageal cancer cell lines. ( Konishi, Y; Nishiwaki, K; Zhang, A; Zhou, R, 2023) |
| "Propofol has been reported to be related to the migration, invasion, and epithelial-mesenchymal transition (EMT) of esophageal cancer (EC) cells." | 1.56 | Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis. ( Gao, M; Guo, R; Lu, X; Luo, S; Xu, G, 2020) |
| "Propofol-based sedation without endotracheal intubation is safe for ESD procedures in the esophagus and stomach with low anesthesia-related complication rates and short hospital stay." | 1.51 | Propofol sedation without endotracheal intubation is safe for endoscopic submucosal dissection in the esophagus and stomach. ( Bruno, MJ; Hilkemeijer, T; Klimek, M; Koch, AD; Leliveld, L; van de Ven, S, 2019) |
| " MAC did not cause any adverse effects requiring prolongation of hospitalization." | 1.42 | Safety and effectiveness of propofol-based monitored anesthesia care without intubation during endoscopic submucosal dissection for early gastric and esophageal cancers. ( Abe, S; Kawaguchi, Y; Kinjo, Y; Nakamura, J; Nonaka, S; Oda, I; Saito, Y; Sato, C; Sato, T; Suzuki, H; Yoshinaga, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, R | 1 |
| Konishi, Y | 1 |
| Zhang, A | 1 |
| Nishiwaki, K | 1 |
| Gao, M | 1 |
| Guo, R | 1 |
| Lu, X | 1 |
| Xu, G | 1 |
| Luo, S | 1 |
| Ashikari, K | 1 |
| Nonaka, T | 1 |
| Higurashi, T | 1 |
| Takatsu, T | 1 |
| Yoshihara, T | 1 |
| Misawa, N | 1 |
| Arimoto, J | 1 |
| Kanoshima, K | 1 |
| Matsuura, T | 1 |
| Fuyuki, A | 1 |
| Ohkubo, H | 1 |
| Chiba, H | 1 |
| Nakajima, A | 1 |
| Ominami, M | 1 |
| Nagami, Y | 1 |
| Shiba, M | 1 |
| Tominaga, K | 1 |
| Sakai, T | 1 |
| Maruyama, H | 1 |
| Kato, K | 1 |
| Minamino, H | 1 |
| Fukunaga, S | 1 |
| Tanaka, F | 1 |
| Sugimori, S | 1 |
| Kamata, N | 1 |
| Machida, H | 1 |
| Yamagami, H | 1 |
| Tanigawa, T | 1 |
| Watanabe, T | 1 |
| Fujiwara, Y | 1 |
| Arakawa, T | 1 |
| Zhang, GH | 1 |
| Wang, W | 1 |
| van de Ven, S | 1 |
| Leliveld, L | 1 |
| Klimek, M | 1 |
| Hilkemeijer, T | 1 |
| Bruno, MJ | 1 |
| Koch, AD | 1 |
| Xu, YB | 2 |
| Du, QH | 1 |
| Zhang, MY | 1 |
| Yun, P | 1 |
| He, CY | 1 |
| Zhao, X | 2 |
| Jin, YW | 1 |
| Li, HB | 1 |
| Wang, ZG | 1 |
| Feng, H | 2 |
| Feng, C | 1 |
| Guo, JR | 1 |
| Guo, W | 1 |
| Jin, XJ | 1 |
| Yu, J | 1 |
| Jin, BW | 1 |
| Xu, F | 1 |
| Liu, Y | 1 |
| Nonaka, S | 1 |
| Kawaguchi, Y | 1 |
| Oda, I | 1 |
| Nakamura, J | 1 |
| Sato, C | 1 |
| Kinjo, Y | 1 |
| Abe, S | 1 |
| Suzuki, H | 1 |
| Yoshinaga, S | 1 |
| Sato, T | 1 |
| Saito, Y | 1 |
| Qiao, Y | 1 |
| Zhao, T | 1 |
| Yan, H | 1 |
| Zhang, H | 1 |
| Guo, XG | 1 |
| Wang, S | 1 |
| Zhuang, J | 1 |
| Zhou, CL | 1 |
| Li, JJ | 1 |
| Ji, P | 1 |
| Mali, AR | 1 |
| Patil, VP | 1 |
| Pramesh, CS | 1 |
| Mistry, RC | 1 |
| Zhang, LM | 1 |
| Zhang, MX | 1 |
| Wang, N | 1 |
| Duan, XY | 1 |
| Zhou, SN | 1 |
| Wang, JS | 1 |
| Jing, GX | 1 |
| Song, JG | 1 |
| Shin, JW | 1 |
| Lee, EH | 1 |
| Choi, DK | 1 |
| Bang, JY | 1 |
| Chin, JH | 1 |
| Choi, IC | 1 |
| Liu, HL | 1 |
| Zhang, Y | 1 |
| Zheng, GL | 1 |
| Rong, QH | 1 |
| Zhao, GL | 1 |
| Xie, JP | 1 |
| Wang, LX | 1 |
| Hanazaki, M | 1 |
| Taga, N | 1 |
| Nakatsuka, H | 1 |
| Yokoyama, M | 1 |
| Morita, K | 1 |
| Shirakawa, Y | 1 |
| Yamatsuji, T | 1 |
| Naomoto, Y | 1 |
| Hiraki, T | 1 |
| Abe, K | 1 |
| Shimizu, T | 1 |
| Takashina, M | 1 |
| Shiozaki, H | 1 |
| Yoshiya, I | 1 |
| Wong, AY | 1 |
| Lawmin, JC | 1 |
| Irwin, MG | 1 |
| Fujiwara, C | 1 |
| Hirose, Y | 1 |
| Gamo, M | 1 |
| Harigae, M | 1 |
| Matsuo, K | 1 |
| Puebla, G | 1 |
| Boimorto, R | 1 |
| de la Calle, JL | 1 |
| de la Casa, R | 1 |
| Igea, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of the Effects of Total Intravenous Anesthesia and Inhalation Anesthesia on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and the Mechanism Involved: a Single-center, Randomized, Prospective Study[NCT03193710] | 260 participants (Anticipated) | Observational | 2017-09-01 | Recruiting | |||
| A Randomized Pilot Clinical Trial of the Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction of Sevoflurane in Patient's Whit ARDS Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)[NCT04998253] | Early Phase 1 | 24 participants (Actual) | Interventional | 2020-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 trials available for propofol and Cancer of Esophagus
| Article | Year |
|---|---|
Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection.
Topics: Conscious Sedation; Dexmedetomidine; Endoscopic Mucosal Resection; Esophageal Neoplasms; Humans; Hyp | 2021 |
Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial.
Topics: Aged; Alcohol Drinking; Anesthetics, Intravenous; Endoscopic Mucosal Resection; Esophageal Neoplasms | 2018 |
Effects of maintaining intravenous infusion of remifentanil or propofol on anesthesia and palinesthesia during anesthesia and analepsia.
Topics: Adult; Aged; Anesthesia; Esophageal Neoplasms; Female; Hemodynamics; Humans; Infusions, Intravenous; | 2014 |
Effects of stellate ganglionic block on hemodynamic changes and intrapulmonary shunt in perioperative patients with esophageal cancer.
Topics: Aged; Anesthesia, General; Autonomic Nerve Block; Esophageal Neoplasms; Female; Hemodynamics; Humans | 2014 |
Postoperative cognitive dysfunction after inhalational anesthesia in elderly patients undergoing major surgery: the influence of anesthetic technique, cerebral injury and systemic inflammation.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Cognition Disorders; Double-Blind Method; E | 2015 |
Incidence of post-thoracotomy pain: a comparison between total intravenous anaesthesia and inhalation anaesthesia.
Topics: Acute Pain; Adolescent; Adult; Aged; Analgesics; Anesthesia, Inhalation; Anesthesia, Intravenous; An | 2012 |
[Clinical observation of injection of dexmedetomidine in anaesthesia for esophageal cancer operation].
Topics: Adjuvants, Anesthesia; Adult; Aged; Analgesics, Non-Narcotic; Anesthetics, Intravenous; Dexmedetomid | 2011 |
Feasibility and safety of endoscopic submucosal dissection of esophageal or gastric carcinomas under general anesthesia.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Diazepam; Endoscopy, Gastrointestinal; Esophage | 2013 |
Anesthetic management of radiofrequency ablation of mediastinal metastatic lymph nodes adjacent to the trachea.
Topics: Anesthesia, General; Anesthetics, Intravenous; Body Temperature; Catheter Ablation; Esophageal Neopl | 2006 |
The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt fraction during one-lung ventilation.
Topics: Adult; Aged; Anesthetics, Inhalation; Esophageal Neoplasms; Female; Hemodynamics; Humans; Intraopera | 1998 |
13 other studies available for propofol and Cancer of Esophagus
| Article | Year |
|---|---|
Propofol elicits apoptosis and attenuates cell growth in esophageal cancer cell lines.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Humans; Hypnotics | 2023 |
Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis.
Topics: Cell Movement; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Female; Humans; Hypnotics an | 2020 |
Effects of sevoflurane and propofol on the development of pneumonia after esophagectomy: a retrospective cohort study.
Topics: Aged; Anesthetics, Inhalation; Cohort Studies; Esophageal Neoplasms; Esophagectomy; Female; Hospital | 2017 |
Propofol sedation without endotracheal intubation is safe for endoscopic submucosal dissection in the esophagus and stomach.
Topics: Aged; Analgesics, Opioid; Anesthetics, Intravenous; Cough; Endoscopic Mucosal Resection; Esophageal | 2019 |
Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Esophageal Neoplasm | 2013 |
Safety and effectiveness of propofol-based monitored anesthesia care without intubation during endoscopic submucosal dissection for early gastric and esophageal cancers.
Topics: Aged; Case-Control Studies; Deep Sedation; Dissection; Early Detection of Cancer; Esophageal Neoplas | 2015 |
Propofol suppresses invasion, angiogenesis and survival of EC-1 cells in vitro by regulation of S100A4 expression.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relation | 2015 |
Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Esop | 2017 |
Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome?
Topics: Analgesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Dose-Response Relationship, Drug | 2009 |
[Effect of low dose propofol on biological behavior of esophageal squamous cell carcinoma cell line Eca109].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Respo | 2011 |
Anaesthetic management of a patient with low tracheal obstruction requiring placement of a T-Y stent.
Topics: Anesthesia; Anesthetics, Combined; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Bronc | 2000 |
[Anesthetic management for placement of tracheobronchial stents in patients with airway stenosis].
Topics: Adult; Aged; Anesthesia, Intravenous; Esophageal Neoplasms; Female; Fentanyl; Humans; Lung Neoplasms | 2000 |
[Anesthesia in a case of Bardet-Biedl syndrome].
Topics: Adenocarcinoma; Adult; Anesthesia; Anesthetics; Bardet-Biedl Syndrome; Esophageal Neoplasms; Esophag | 2001 |